Pharmacological Therapeutics
Mostrando 1-12 de 18 artigos, teses e dissertações.
-
1. Systematic review of pharmacological management in Creutzfeldt-Jakob disease: no options so far?
Resumo Antecedentes A doença de Creutzfeldt-Jakob (DCJ) é uma encefalopatia espongiforme que se manifesta como síndrome demencial rapidamente progressiva. Atualmente, a DCJ não possui cura e muitos pacientes morrem no primeiro ano de doença, mas alguns medicamentos vêm sendo estudados como opções no manejo desta condição. Objetivo Avaliar a efic�
Arquivos de Neuro-Psiquiatria. Publicado em: 2022
-
2. Medication-related inpatient falls: a critical review
Abstract Falls are the second leading cause of accidental and unintentional injury deaths worldwide. Inpatient falls in hospital settings are likely to prolong the length of stay of patients in nearly 6.3 days, leading to increased hospitalization costs. The causes of fall incidents in healthcare facilities are multifactorial in nature and certain medication
Braz. J. Pharm. Sci.. Publicado em: 07/06/2018
-
3. Isolation and identification of cytotoxic compounds from a fruticose lichen Roccella montagnei, and it's in silico docking study against CDK-10
ABSTRACT Roccella montagnei Bél. belongs to lichen family Roccelleceae growing luxuriantly along the coastal regions of India. As Roccella has been shown to be bioactive, we prepared methanolic extract and assessed its anticancer potential. The methanolic extract showed significant in vitro cytotoxic activity against four human cancer cell lines such as col
Rev. bras. farmacogn.. Publicado em: 2017-12
-
4. Utilização farmacológica de um composto inédito derivado de quinazolina como inibidor potencial da quinase de adesão focal (FAK) no processo de hipertrofia cardíaca em camundongo = : Pharmacological use of a novel compound quinazoline derivative as potential inhibitor of the focal adhesion kinase in the process of cardiac hypertrophy in mice / Pharmacological use of a novel compound quinazoline derivative as potential inhibitor of the focal adhesion kinase in the process of cardiac hypertrophy in mice
Nas doenças do coração ocorre hipertrofia e remodelamento do ventrículo esquerdo com impacto negativo na evolução clínica. Esses fatores influenciam independentemente o risco cardiovascular por elevarem a predisposição a infartos do miocárdio, ao desenvolvimento de insuficiência cardíaca e ao aparecimento de arritmias ventriculares graves. Estrut
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 06/07/2012
-
5. LEISHMANIOSE TEGUMENTAR AMERICANA: uma abordagem farmacológica
The leishmaniasis (ACL) is a zoonotic disease whose etiologic agent, species of the genus Leishmania. And a disease of the skin and mucous membranes, primarily zoonotic involving a variety of wild and domestic mammals. Outbreaks of leishmaniasis occur by environmental changes due to deforestation, construction of dams, roads, mines, plant work areas, militar
Publicado em: 2009
-
6. Avaliação dos efeitos de extrato de Pterodon pubescens em ratos com sepse
Pterodon pubescens é uma árvore nativa do cerrado amplamente utilizada em práticas de cuidados com a saúde por populações tradicionais do país, principalmente quando envolve quadros inflamatórios. O presente trabalho buscou avaliar o efeito protetor do pré-tratamento com extrato hexânico de Pterodon pubescens (LDT-PPH) em ratos com sepse severa, s�
Publicado em: 2009
-
7. AVALIAÇÃO DA ATIVIDADE FARMACOLÓGICA DE Cissus verticillata Nicolson &C. E. Jarvis subsp. verticillata COMO ANTIOXIDANTE, ANTIFÚNGICO, HIPOGLICEMIANTE E CICATRIZANTE / Assessment of pharmacological activity of Cissus verticillata Nicolson &C. E. Jarvis subsp. verticillata as antioxidant, antifungal, hypoglycaemic and healing
BRAGA, Tatiane Vieira. Universidade Federal de Ouro Preto, july,2008. Assessment of pharmacological activity of Cissus verticillata Nicolson &C. E. Jarvis subsp. verticillata as antioxidant, antifungal, hypoglycaemic and healing. Adviser: Tanus Jorge Nagem. Co-advisor: Tânia Toledo de Oliveira. The species Cissus verticillata (L.) Nicolson &C. E. Jarvis sub
Publicado em: 2008
-
8. Estudo comparativo entre faseolamina comercial e farinha de feijÃo como perspectiva ao tratamento da obesidade e do diabetes mellitus tipo 2. / Comparative study between commercial phaseolamine and bean flour as a perspective to the treatment of obesity and type 2 diabetes mellitus.
Use of plants of medicinal purposes represents a wide field of research. New therapeutic proposals need studies to evaluate the appropriate use as to posology, indication, limitations and risks of utilization. The search for new phytotherapeutic ones as an alternative to the traditional medicinal treatment of obesity and of the type 2 diabetes mellitus has b
Publicado em: 2008
-
9. HIPERTENSÃO ARTERIAL EM OURO PRETO (MG): AVALIAÇÃO DA TERAPÊUTICA FARMACOLÓGICA E DE FATORES DE RISCO CARDIOVASCULARES.
Hypertension is one of the main risk factors for cardiovascular diseases and may occur associated with other risk factors that are independently associated with cardiovascular diseases such as social-demographic, behavior and clinical factors. Measures of non-pharmacological and pharmacological therapeutics to treat hypertension are available, despite poor b
Publicado em: 2006
-
10. An overview of the effects of annexin 1 on cells involved in the inflammatory process
The concept of anti-inflammation is currently evolving with the definition of several endogenous inhibitory circuits that are important in the control of the host inflammatory response. Here we focus on one of these pathways, the annexin 1 (ANXA1) system. Originally identified as a 37 kDa glucocorticoid-inducible protein, ANXA1 has emerged over the last deca
Memórias do Instituto Oswaldo Cruz. Publicado em: 2005-03
-
11. Estudo, em ambiente hospitalar, da utilização de medicamentos que atuam no sistema nervoso central
The purpose of this research was to evaluate the utilization of medicines in hospitais specially those ones that act in the Central Nervous System (C.N.S.), analyzing the prescription frequency of different pharmacological groups and through each therapeutics group that act in the C.N.S. and also the involved cost in each therapeutics group, drug and clinic.
Publicado em: 1996
-
12. The pharmacological basis of therapeutics
BMJ Group.